mRNA expression of iron regulatory genes in β-thalassemia intermedia and β-thalassemia major mouse models

American Journal of Hematology

Volumn 81, Issue 7, 2006, Pages 479-483

  Weizer Stern, Orly ^a   Adamsky, Konstantin ^a   Amariglio, Ninette ^a   Rachmilewitz, Eliezer ^b   Breda, Laura ^c   Rivella, Stefano ^c   Rechavi, Gideon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

thalassemia; Hepcidin; HFE; IREG; Iron absorption; Murine; NGAL; Transferrin receptor

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEPCIDIN; IRON; MESSENGER RNA; TRANSFERRIN RECEPTOR;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC REGULATION; HIGH RISK PATIENT; INTESTINE ABSORPTION; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-THALASSEMIA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION PROFILING; GENES, REGULATOR; GLOBINS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON OVERLOAD; MICE; ONCOGENE PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 33745684771     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20549     Document Type: Article

References (30)

1. Gu X, Zeng Y. A review of the molecular diagnosis of thalassemia. Hematology 2002;7:203-209.
2. Weatherall DJ, Pressley L, Wood WG, Higgs DR, Clegg JB. Molecular basis for mild forms of homozygous beta-thalassemia. Lancet 1981;1:527-529.
3. Rachmilewitz E, Schrier S. Pathophysiology of beta-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge, England: Cambridge University Press; 2001. p 233-251.
4. Hoffbrand AV. Diagnosing myocardial iron overload. Eur Heart J 2001;22:2140-2141.
5. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-761.
6. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-150.
7. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.
8. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-788.
9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
10. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98:8780-8785.
11. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596-4601.
12. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-3781.
13. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819.
14. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463.
15. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29:327-335.
16. Adamsky K, Weizer O, Amariglio N, et al. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 2004;124:123-124.
17. Rivella S, May C, Chadburn A, Riviere I, Sadelain M. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 2003;101:2932-2939.
18. Wallace DF, Summerville E, Lusby PE, Subramaniam VN. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut 2005;54:980-986.
19. Courselaud B, Troadec MB, Fruchon S, et al. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol Dis 2004;32:283-289.
20. Frazer DM, Inglis HR, Wilkins SJ, et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004;53:1509-1515.
21. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
22. Barisani D, Paralioriti A, Armiraglio R, Meneveri R, Conte D. Duodenal expression of a putative stimulator of Fe transport and transferrin receptor in anemia and hemochromatosis. Gastroenterology 2001;120:1404-1411.
23. Rouault T, Klausner R. Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 1997;35:1-19.
24. Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 2004;104:4287-4293.
25. Kawabata H, Fleming RE, Gui D, et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 2005;105:376-381.
26. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005;105:1803-1806.
27. Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002;10:1045-1056.
28. al-Refaie F, Wickens D, Wonke B, Kontoghiorghes G, Hoffbrand A. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. Br J Haematol 1992;82:431-436.
29. Anderson G. Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999;14:105-108.
30. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood 2005;105:4103-4105.